packageSelumetinib

selumetinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Selumetinib is a MEK inhibitor anticancer drug used to treat neurofibromatosis 1 and has been studied for low-grade serous carcinoma. It is authorised in the European Union for neurofibromatosis 1 and is also under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q7448840 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:selumetinib
ATC codes:L01EE04
DrugBank:DB11689
PubChem CID:10127622
ChEBI:90227
Wikidata:Q7448840
formula:C17H15BrClFN4O3
molar mass:457.684 g/mol (PubChem CID 10127622)
logP:3.6 (Drugs.Common 25.09, not verified)

Metabolites

NDesmethylSelumetinibN-desmethyl-selumetinib443.657 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
NDesmethylSelumetinibmetabolite: N-desmethyl-selumetinib